Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
01/2000
01/05/2000EP0968277A1 Filtration method for separating viruses
01/05/2000EP0967991A1 Infectious bursitis vaccine
01/04/2000US6010895 Non-pathogenic strains of HIV-1 containing mutations in the NEF gene or the U3 region of the long terminal repeat
01/04/2000US6010894 Using brain membrane receptor; forming vaccines
01/04/2000US6010703 Genetic engineering; inserting gene into gene encoding thymidine kinase
12/1999
12/29/1999WO1999067394A1 Vector expressing the full-length gene of rna virus and use thereof
12/29/1999WO1999067366A1 Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein
12/29/1999WO1999067362A1 Process for the in vitro replication of hcv
12/29/1999WO1999067285A1 Particles of hcv envelope proteins: use for vaccination
12/29/1999WO1999060147A3 Targeted delivery through a cationic amino acid transporter
12/29/1999WO1999057284A3 Attenuated influenza viruses
12/29/1999EP0966976A1 Method for removal of HIV from a solution
12/29/1999EP0966527A1 Method for inducing mutations and the use thereof in the production of a vaccine against pathogenic microorganisms
12/29/1999EP0966524A1 A process for purification of pcr test samples
12/29/1999EP0966301A1 Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression
12/29/1999CA2334767A1 Process for the in vitro replication of hcv
12/29/1999CA2330526A1 Particles of hcv envelope proteins: use for vaccination
12/28/1999US6008047 Cell culturing method and medium
12/28/1999US6008036 Introducing the viruses in cell culture medium onto an anion exchange chromatography column, eluting the virus of interest then introducing the eluted virus into a cation exchange chromotography column, eluting purified virus; vaccines
12/28/1999US6008035 System for the in vivo delivery and expression of heterologous genes in the bone marrow
12/23/1999WO1999066061A1 Nucleic acid transfer phage
12/23/1999WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999066045A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999WO1999065871A2 Thiolesters and uses thereof
12/23/1999WO1999053043A3 Herpes simplex virus latency associated transcript polypeptides
12/23/1999WO1999040212A3 Bacteriophage vectors generated by bacteriophage/plasmid recombination
12/23/1999CA2335464A1 Novel thiolesters and uses thereof
12/23/1999CA2334165A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331384A1 Nucleic acid transfer phage
12/23/1999CA2276785A1 Process for separating hiv from a fluid
12/22/1999EP0965639A1 Attenuated pestiviruses
12/22/1999EP0965345A2 Use of acemannan
12/22/1999EP0964922A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
12/22/1999EP0964916A1 Viral variants and methods for detecting same
12/22/1999CN1047630C Method and reagents for hepatitis C detection
12/21/1999US6005079 Used for diagnosis or therapeutical purposes including protection against pathological agents or regulation of the expression or activity of proteins
12/21/1999US6004799 Recombinant live feline immunodeficiency virus and proviral DNA vaccines
12/21/1999US6004798 Retroviral envelopes having modified hypervariable polyproline regions
12/21/1999US6004797 Adenovirus helper-free recombinant AAV Virion production
12/21/1999CA2065842C Process for inactivating viruses in blood and blood products
12/16/1999WO1999064604A2 Attenuated pestiviruses
12/16/1999WO1999064577A1 Novel adenoviral vectors for gene therapy
12/16/1999WO1999064571A1 Interferon inducing genetically engineered attenuated viruses
12/16/1999WO1999064570A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999WO1999064068A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999WO1999049017A3 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
12/16/1999CA2334895A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/16/1999CA2334850A1 Novel methods and interferon deficient substrates for the propagation of viruses
12/16/1999CA2329947A1 Novel adenoviral vectors for gene therapy
12/15/1999EP0963434A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
12/15/1999EP0623167B1 Preparation of mystery disease virus antigens and vaccines and antigens and vaccines produced for the prevention of this disease
12/14/1999US6001987 Isolated nucleotide sequences associated with Multiple sclerosis
12/14/1999US6001650 High-efficiency wild-type-free AAV helper functions
12/14/1999US6001634 Recombinant negative strand RNA viruses
12/14/1999US6001591 Recombinant bovine adenoviruses
12/14/1999US6001557 Polycation conjugate coding defective virus which reduces the packaging efficiency virus, a minigene and sequences which allow for efficiect viral infection; for gene therapy
12/14/1999US6001371 Relates to recombinant baculoviruses encoding parvovirus structural proteins and host cells infected therewith; method of packaging and delivering genetic information utilizing the noninfectious capsids
12/14/1999US6001370 New attenuated strain allows the obtaining of vaccines and diagnostic kits which make possible both the early diagnosis of porcine reproductive respiratory syndrome and an efficient preventive treatment of such disease
12/14/1999US6001369 Recombinant fowlpox virus comprising a foreign dna inserted into the fowlpox virus genomic dna, wherein the foreign dna sequence is inserted within a fragment of the fowlpox virus genomic dna and is capable of being expressed in host cell
12/09/1999WO1999063064A1 Novel methods for rescue of rna viruses
12/09/1999WO1999063063A1 Cellular proteins which mediate herpesvirus entry
12/09/1999WO1999063062A1 Genetically manipulated entomopoxvirus
12/09/1999WO1999062500A1 Stabilizers for lyophilized vaccines
12/09/1999WO1999051749A3 Recombinant potyvirus construct and use thereof
12/09/1999WO1999044943A3 Vectors and viruses used in gene therapy
12/09/1999DE19825129A1 Use of biological substances as dendrimers, fullerenes and lubricants
12/09/1999CA2333505A1 Stabilizers for lyophilized vaccines
12/08/1999EP0962525A1 Phage bonded to nuclear location signal
12/08/1999CN1237456A Epidemic hemorrhagic fever passage cell polyvalent purified vaccine
12/07/1999US5998208 Human gene therapy.
12/07/1999US5998192 For use in many human gene therapy protocols, especially those requiring transduction of normal or neoplastic haemopoietic cells.
12/07/1999US5997943 Compound for a non-wettable coating, process for treatment of glass with the aid of the compound and products obtained
12/07/1999US5997880 Method for alleviating varicella related post-herpetic neuralgia
12/07/1999US5997878 Recombinant poxvirus-cytomegalovirus, compositions and uses
12/07/1999US5997859 Gene encoding a conditionally lethal gene product which activates a purine- or pyrimidine-based prodrug into an agent that is cytotoxic to said metastatic carcinoma; and administering said prodrug to said patient
12/02/1999WO1999061643A1 Method of preparing recombinant adeno-associated virus compositions by using an iodixananol gradient
12/02/1999WO1999061642A1 Recombinant aav vectors for gene therapy of hemophilia a
12/02/1999WO1999061639A2 Retroviral delivery system
12/02/1999WO1999061638A1 Chimeric adenoviral vectors
12/02/1999WO1999061637A1 Gene sequences of rubella virus associated with attenuation
12/02/1999WO1999061636A1 Recombinant cytomegalovirus expression system targeting the immediate-early gene region
12/02/1999WO1999061621A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999WO1999061601A2 Aav5 vector and uses thereof
12/02/1999WO1999061069A1 Materials and methods for delivery and expression of heterologous dna in vertebrate cells
12/02/1999WO1999061052A2 Oral immunization with papillomavirus virus-like particles
12/02/1999WO1999061049A2 Model for infection by a pathogen using administration of nucleic acids
12/02/1999WO1999050424A3 Fusion protein comprising a sequence from a major coat protein of a papovavirus
12/02/1999CA2745131A1 Aav5 vector and uses thereof
12/02/1999CA2329505A1 Recombinant aav vectors for gene therapy of hemophilia a
12/02/1999CA2329136A1 Oral immunization with papillomavirus virus-like particles
12/02/1999CA2328491A1 Retroviral delivery system
12/02/1999CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999CA2298070A1 Gene sequences of rubella virus associated with attenuation
12/02/1999CA2298064A1 Chimeric adenoviral vectors
12/01/1999EP0960194A1 Vectors and methods for tissue specific synthesis of protein in eggs of transgenic hens
12/01/1999EP0959901A1 A method for generating birnavirus from synthetic rna transcripts
12/01/1999CN1237209A Herpesvirus saimiri as viral vector
11/1999
11/30/1999US5994137 Obtaining mycobacteriophage with an escherichia bacteriophage cosmid and a transposon inserted in a non-essential region, infecting the bacterium with the phasmid to deliver the transposon to the bacterium chromosome causing gene mutations
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 267